- Home
- / C.H. Boehringer Sohn
C.H. Boehringer Sohn
Revenue
€19.6 B
FY, 2020
C.H. Boehringer Sohn Summary
Company Summary
- Overview
- C.H. Boehringer Sohn is a holding company engaged in pharma development. It focuses on respiratory diseases, metabolism, immunology, oncology, and diseases of the central nervous system. The company operates globally.
- Type
- Private
- Status
- Active
- Founded
- 1885
- HQ
- Ingelheim am Rhein, DE | view all locations
Table of Contents
LocationsView all
1 location detected
Ingelheim am Rhein, RP HQ
Germany
Binger Str. 173
C.H. Boehringer Sohn Financials
Summary Financials
- Revenue (FY, 2020)
- €19.6B
- Gross profit (FY, 2020)
- €17.0B
- Net income (FY, 2020)
- €3.1B
- Cash (FY, 2020)
- €4.6B
- EBIT (FY, 2020)
- €4.6B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026